Earnings · China A-shares
China National Accord Medicines Corporation Ltd Class A (000028) earnings
China National Accord Medicines Corporation Ltd Class A published its Q3 report on 2026-10-30: net profit -0.48% year on year, +2.36% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +3.09% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -0.48%
- Excl. one-offs YoY
- +2.36%
- Net profit QoQ
- +8.64%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.81% | — |
| 3 days | +3.09% | — |
| 7 days | +0.33% | — |
| 14 days | -0.24% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +0.43%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | ¥952.49M | -0.48% | +2.36% | -0.11% | 1.56 | 5.03% | +3.09% | — | — |
| 2026 interim report | 2026-08-29 | ¥606.20M | -8.97% | -6.84% | -1.44% | 0.99 | 3.21% | +0.25% | +2.35% | +11.69% |
| 2026 Q1 report | 2026-04-30 | ¥287.46M | -12.36% | -11.77% | -2.57% | 0.52 | 1.53% | -1.13% | -8.02% | -10.08% |
| 2025 annual report | 2026-04-02 | ¥1.14B | +76.80% | +88.53% | -1.29% | 2.04 | 6.26% | +0.83% | -8.59% | -16.09% |
| 2025 Q3 report | 2025-10-31 | ¥957.12M | -10.18% | -9.87% | -2.38% | 1.72 | 5.29% | -0.39% | -1.69% | +2.99% |
| 2025 interim report | 2025-08-30 | ¥665.91M | -10.43% | -9.63% | -2.62% | 1.20 | 3.70% | -1.74% | -1.98% | -2.82% |
| 2025 Q1 report | 2025-04-25 | ¥328.00M | -15.63% | -14.14% | -4.17% | 0.59 | 1.84% | -0.04% | +5.66% | +2.42% |
| 2024 annual report | 2025-04-08 | ¥642.49M | -59.83% | -62.08% | -1.46% | 1.15 | 3.67% | +2.54% | +4.62% | -3.93% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.